TotalMarketCap

Pliant Therapeutics

PLRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$50.516 M

$0.82 -4.23%

Close of 6 Nov 2026

As of 6 Nov 2026, Pliant Therapeutics (PLRX) has a market capitalization of $50.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

$149.3M

#1119 by earnings

Shares outstanding

61,921,897

Latest filing cover page

P/E ratio

0.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #333Heron TherapeuticsHRTX$52.8M
  2. #334TalpheraTLPH$52.7M
  3. #335Pliant TherapeuticsPLRX$50.5M
  4. #336ApollomicsAPLM$49.5M
  5. #337IntercureINCR$49.4M

What if Pliant Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$456,007.89

Per share 558,970× higher

Bitcoin $1.53T

$24,673.79

Per share 30,245× higher

Apple $5.02T

$81,001.76

Per share 99,291× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Pliant Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.